The study showed that an experimental pill from the company Revolution Medicines almost doubled metastatic pancreatic cancer patients’ survival times compared with chemotherapy.
The researchers used machine learning on genetic sequence data to design a super-antigen containing features common across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results